VERTEX PHARMACEUTICALS INC / MA Operating Leases, Future Minimum Payments Due, Next Twelve Months
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $85.07 million as of 2018-12-31, per its 10-K filed 2020-02-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2020-02-13
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $85.07M.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $84.45M.
- 2016-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $87.91M.
- 2015-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $85.60M.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $85.07M 10-K · filed 2020-02-13 |
| 2017-12-31 | $84.45M 10-K · filed 2018-02-15 |
| 2016-12-31 | $87.91M 10-K · filed 2017-02-23 |
| 2015-12-31 | $85.60M 10-K · filed 2016-02-16 |
| 2014-12-31 | $104.39M 10-K · filed 2015-02-13 |
| 2013-12-31 | $119.30M 10-K · filed 2014-02-11 |
| 2012-12-31 | $136.31M 10-K · filed 2013-03-01 |
| 2011-12-31 | $46.87M 10-K · filed 2012-02-22 |
| 2010-12-31 | $40.99M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |